Please ensure Javascript is enabled for purposes of website accessibility

Buffett's Rohming, Too

By David Smith – Updated Nov 11, 2016 at 6:10PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Dow's paying up for Rohm & Haas, but the deal looks good.

If you're seeking a quality combination in a volatile market, I think there's a lot to like about Dow Chemical's (NYSE:DOW) newly announced acquisition of rival Rohm and Haas (NYSE:ROH).

For starters, there's the -- oh, how I hate this word -- synergistic nature of the pairing. Dow will be able to add the higher-margin specialty chemicals business from Rohm and Haas to its own basic chemicals operations.

Then there's the comfort of knowing that the Oracle of Omaha backed the deal with his company's dough. Warren Buffett, through Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B), is funding $3 billion of the combination, in exchange for convertible preferred securities. Once the deal has closed -- probably early next year -- Berkshire Hathaway will be Dow's biggest shareholder.

The deal, which was announced Thursday, isn't cheap. Dow will pay $78 for each of Rohm and Haas' shares, a whopping 74% premium to Rohm's Wednesday closing price of $44.83. That said, it looks like the merger will result in big cost savings, perhaps as much as $800 million a year pre-tax. Rohm and Haas had nearly $9 billion in 2007 revenue, compared to Dow's $54 billion. Among the company's holdings is Morton Salt, so the deal is clearly worth its ... no, I won't go there.

Along with Buffett's backing, the Kuwaiti Investment Authority is chipping in another $1 billion, also in exchange for convertible preferred securities. And amid a credit crunch, it's also somewhat comforting to have a debt commitment from Citigroup (NYSE:C), Merrill Lynch (NYSE:MER), and Morgan Stanley.

With both Dow and its rival chemicals giant DuPont (NYSE:DD) having become truly global operations, the deal will provide Dow with new arrows for its expansionary quiver. As for that market volatility consideration: These days, it's good to have a big company like Dow clearly plowing new -- and likely fertile -- ground.

For related Foolishness:

None

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Berkshire Hathaway Inc. Stock Quote
Berkshire Hathaway Inc.
BRK.A
$404,485.25 (-0.22%) $-889.76
Berkshire Hathaway Inc. Stock Quote
Berkshire Hathaway Inc.
BRK.B
$267.77 (-0.28%) $0.74
DuPont de Nemours, Inc. Stock Quote
DuPont de Nemours, Inc.
DOW
Citigroup Inc. Stock Quote
Citigroup Inc.
C
$44.26 (-2.90%) $-1.32
E. I. du Pont de Nemours and Company Stock Quote
E. I. du Pont de Nemours and Company
DD

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
339%
 
S&P 500 Returns
109%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.